Inhibrx Biosciences Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

12.20

-0.12 (-0.97%)

At close: May 02, 2025, 3:59 PM

12.15

-0.37%

After-hours: May 02, 2025, 04:01 PM EDT

Inhibrx Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	1.69B	-239.73M	-145.23M	-81.77M	-76.12M	-51.4M	-31.02M	-22.08M	-8.27M
Depreciation & Amortization	2.29M	1.19M	1.23M	1.2M	1.02M	1.16M	676K	399K	253K
Stock-Based Compensation	58.52M	24.85M	17.79M	15.05M	5.02M	3.97M	2.48M	1.18M	552K
Other Working Capital	33.77M	13.76M	3.74M	-1.67M	-5.61M	8.94M	556K	-556K	-6.35M
Other Non-Cash Items	-1.99B	5.03M	5.09M	2.73M	11.56M	9.61M	522K	746K	-3.37M
Deferred Income Tax	n/a	n/a	n/a	-9K	-2.14M	1.08M	n/a	n/a	n/a
Change in Working Capital	52.05M	15.35M	3.16M	-17.52M	12.69M	3.48M	4.25M	999K	-6.28M
Operating Cash Flow	-194.41M	-193.31M	-115.3M	-80.32M	-47.97M	-32.08M	-23.09M	-18.75M	-18.11M
Capital Expenditures	-2.6M	-4.59M	-686K	-864K	-1.36M	-1.81M	-1.43M	-1.34M	-215K
Cash Acquisitions	n/a	n/a	n/a	55K	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	55K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-2.6M	-4.59M	-686K	-809K	-1.36M	-1.81M	-1.43M	-1.34M	-215K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	-828K	-1.38M	n/a
Other Financial Acitivies	71.68M	201.96M	128.81M	83.77M	166.46M	43.33M	13.98M	14.91M	28.77M
Financial Cash Flow	71.68M	201.96M	258.55M	83.77M	166.46M	43.33M	13.15M	13.54M	28.77M
Net Cash Flow	-125.33M	4.06M	142.56M	2.64M	117.12M	9.44M	-11.37M	-6.55M	10.45M
Free Cash Flow	-197.01M	-197.9M	-115.99M	-81.19M	-49.33M	-33.89M	-24.52M	-20.09M	-18.32M